Skip to content

enVista® IOL MX60PL (REF MXUEPL2850)Recalls & reported problems

Bausch & Lomb Incorporated · enVista one-piece hydrophobic acrylic intraocular lens (preloaded) +28.50D · Class 3 · Implant

All models of enVista IOL (74)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10757770571670), received between Aug 15, 2023 and Aug 15, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Insufficient Device Problem Information1

Patient problems

  • Blurred Vision1
  • Excessive Tear Production1
  • Eye Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 15, 2023Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    ADDITIONAL INFORMATION WAS RECEIVED, INDICATING THE SECONDARY PROCEDURE WAS DUE TO POSTERIOR CAPSULE OPACIFICATION AND IS UNRELATED TO THE DEVICE.

    Patient problems: Blurred Vision; Excessive Tear Production; Eye Pain

    MAUDE report 17552433 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page